Company profile for Korsana Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Korsana is a biotechnology company advancing innovative RNA-based therapies to treat a wide range of diseases. With a focus on cutting-edge RNA science, Korsana develops next-generation therapeutic platforms that unlock the potential of RNA modalities for durable, targeted treatments. The company prioritizes scientific excellence, strategic collaborations, and translational research to bring safe, effective solutions from disc...
Korsana is a biotechnology company advancing innovative RNA-based therapies to treat a wide range of diseases. With a focus on cutting-edge RNA science, Korsana develops next-generation therapeutic platforms that unlock the potential of RNA modalities for durable, targeted treatments. The company prioritizes scientific excellence, strategic collaborations, and translational research to bring safe, effective solutions from discovery to patients worldwide.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
221 Crescent Street
 Building 23, Suite 105
 Waltham, MA 02453
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

IPhEB Russia

Not Confirmed

envelop Contact Supplier

IPhEB Russia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20260316391631/en/Korsana-Biosciences-Appoints-Mark-Vignola-Ph.D.-as-Chief-Financial-Officer

BUSSINESSWIRE
16 Mar 2026

https://www.businesswire.com/news/home/20260312128046/en/Korsana-Biosciences-to-Present-at-the-Stifel-2026-Virtual-CNS-Forum

BUSSINESSWIRE
12 Mar 2026

https://www.businesswire.com/news/home/20260218747210/en/Korsana-Biosciences-Emerges-from-Stealth-with-%24175-Millon-in-Funding-to-Advance-Potential-Best-in-Class-Therapeutics-for-Neurodegenerative-Diseases

BUSINESSWIRE
18 Feb 2026

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty